Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera

PHASE3CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Polycythemia Vera
Interventions
DRUG

Peg-P-IFN-alpha-2b (AOP2014)

Pegylated interferon alpha 2b given Q2W as SC injection

DRUG

Hydroxyurea

Hydroyurea capsules taken daily po

Trial Locations (58)

Unknown

LKH Graz, Graz

University Hospital Innsbruck, Innsbruck

Elisabethinen Hospital Linz, Linz

Salzburg Regional Hospital, Salzburg

Hanusch Hospital, Vienna

Medical University Vienna, Vienna

Hospital Wels-Grieskirchen, Wels

Centre du Cancer et D'hematologie, Brussels

UZA, Antwerp University Hospital, Edegem

UZ Leuven, Leuven

Haematolgy, University of Liège, Liège

"University Multiprofile Hospital for Active Treatment Sveti Georgi", Plovdiv

Specialized Hospital for Active Treatment of Hematological Diseases, Sofia

"Multiprofile Hospital for Active Treatment Sveta Marina", Varna

Multiprofile Hospital for Active Treatment - Hristo Botev, Vratsa, First Department of Internal Medicine, Vratsa

University Hospital Brno, Brno

University Hospital Hradec Kralove, Hradec Králové

Institute of Hematology and Blood Transfusion, Prague

University Hospital Kralovske Vinohrady, Prague

University Hospital Motol, Prague

Institute Paoli-Calmettes, Marseille

Hospital Saint-Louis, Paris

Clinical Research Center CIC, Poitiers

Aachen University Hospital, Medical Clinic IV, Aachen

University Hospital Bonn, Center for Internal Medicine, Medical Clinic and Outpatient Clinic III, Bonn

University Hospital Carl Gustav Carus, Medical Clinic and Polyclinic I, Dresden

St Istvan and St Laszlo Hospital of Budapest, Budapest

University of Debrecen, Debrecen

Bekes County Pandy Kalman Hospital, 1st Department of Medicine, Hematology, Gyula

Kaposi Mor County Teaching Hospital, Kaposvár

University of Szeged, Albert Szent-Gyorgyi Clinical Center, Koranyi fasor 6, Szeged

Careggi University Hospital, Florence

Foundation IRCCS Policlinico San Matteo, Pavia

Andrzej Mielecki Independent Public Clinical Hospital of Medical University of Silesia in Katowice, Katowice

University Hospital in Cracow, Krakow

Independent Public Teaching Hospital No.1 in Lublin, Lublin

Fryderyk Chopin Provincial Specialized Hospital, Rzeszów

Nicolaus Copernicus Municipal Specialist Hospital, Torun

Institute of Hematology and Transfusion Medicine, Warsaw

Emergency Clinical County Hospital Brasov, Brasov

Bucharest University Emergency Hospital, Bucharest

Coltea Clinical Hospital, Bucharest

"Prof. Dr. Ion Chiricuta Institute of Oncology", Cluj-Napoca

Baranov Republican Hospital, Petrozavodsk

First Pavlov State Medical University of St. Petersburg, Saint Petersburg

Samara Kalinin Regional Clinical Hospital, Samara

Komi Republican Oncology Center, Syktyvkar

Tula Regional Clinical Hospital, Tula

Yaroslavl Regional Clinical Hospital, Yaroslavl

University Hospital with Outpatient Clinic F.D. Roosevelt, Banská Bystrica

Saint Cyril and Metod University Hospital Bratislava, Bratislava

Hospital Clinic i Provincial de Barcelona, Barcelona

Hospital del Mar, Barcelona

Cherkasy Regional Oncology Center, Regional Treatment and Diagnostics Hematology Center, Cherkasy

Dnipropetrovsk City Multispecialty Clinical Hospital #4, Dnipropetrovsk

National Research Center for Radiation Medicine, Institute of Clinical Radiology, Kiev

Institute of Blood Pathology and Transfusion Medicine, Lviv

O.F. Herbachevskyi Regional Clinical Hospital, Zhytomyr

Sponsors
All Listed Sponsors
collaborator

PharmaEssentia (Co-Sponsor for USA)

UNKNOWN

lead

AOP Orphan Pharmaceuticals AG

INDUSTRY

NCT01949805 - Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera | Biotech Hunter | Biotech Hunter